Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v6-EN
Language French English
Date Updated 2017-04-12 2017-04-12
Drug Identification Number 02408090 02408090
Brand name MYLAN-BUPRENORPHINE/NALOXONE MYLAN-BUPRENORPHINE/NALOXONE
Common or Proper name Buprenorphine/Naloxone Buprenorphine/Naloxone
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients BUPRENORPHINE NALOXONE BUPRENORPHINE NALOXONE
Strength(s) 2MG 0.5MG 2MG 0.5MG
Dosage form(s) TABLET TABLET
Route of administration SUBLINGUAL SUBLINGUAL
Packaging size 100s 100s
ATC code N07BC N07BC
ATC description DRUGS USED IN ADDICTIVE DISORDERS DRUGS USED IN ADDICTIVE DISORDERS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-03-20 2017-03-20
Estimated end date
Actual end date 2017-04-11 2017-04-11
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments